Incontinence in Phelan-McDermid Syndrome

J Pediatr Gastroenterol Nutr. 2019 Aug;69(2):e39-e42. doi: 10.1097/MPG.0000000000002342.

Abstract

Objective: The aim of the study was to evaluate gastrointestinal symptoms and continence in the context of Phelan-McDermid Syndrome (PMS).

Methods: A prospective evaluation of children with PMS (n = 17) at the National Institutes of Health.

Results: Parent-reported history of symptoms were common: constipation (65%), reflux (59%), choking/gagging (41%), and more than half received gastrointestinal specialty care. No aspiration was noted in 11/11 participants who completed modified barium swallows. Four participants met criteria for functional constipation, 2 of whom had abnormal colonic transit studies. Stool incontinence was highly prevalent (13/17) with nonretentive features present in 12/17. Participants who were continent had significantly smaller genetic deletions (P = 0.01) and higher nonverbal mental age (P = 0.03) compared with incontinent participants.

Conclusions: Incontinence is common in PMS and associated with intellectual functioning and gene deletion size. Management strategies may differ based on the presence of nonretentive fecal incontinence, functional constipation, and degree of intellectual disability for children with PMS.

Trial registration: ClinicalTrials.gov NCT01778504.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Chromosome Deletion*
  • Chromosome Disorders*
  • Chromosomes, Human, Pair 22
  • Fecal Incontinence / genetics
  • Fecal Incontinence / physiopathology*
  • Female
  • Gene Deletion
  • Humans
  • Intellectual Disability*
  • Male
  • Prospective Studies

Supplementary concepts

  • Telomeric 22q13 Monosomy Syndrome

Associated data

  • ClinicalTrials.gov/NCT01778504